BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26881860)

  • 21. Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
    Dryden-Edwards RC; Reiss AL
    J Child Adolesc Psychopharmacol; 1996; 6(2):139-45. PubMed ID: 9231306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth failure associated with the use of high dose prozac (fluoxetine hydrochloride) in a patient with type 1 diabetes mellitus.
    Frank GR; Navon RE
    J Pediatr Endocrinol Metab; 1999; 12(3):467-9. PubMed ID: 10821228
    [No Abstract]   [Full Text] [Related]  

  • 23. Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder.
    Giakas WJ
    Am J Psychiatry; 1995 Jul; 152(7):1097-8. PubMed ID: 7540801
    [No Abstract]   [Full Text] [Related]  

  • 24. Ritanserin as adjunct to fluoxetine treatment of OCD patients with psychotic features.
    Bach M; Aigner M; Lenz G
    Pharmacopsychiatry; 1997 Jan; 30(1):28-9. PubMed ID: 9065968
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug safety evaluation of olanzapine/fluoxetine combination.
    Cristancho MA; Thase ME
    Expert Opin Drug Saf; 2014 Aug; 13(8):1133-41. PubMed ID: 24972823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
    Salmerón JM; Alcántara AG; Barcia D
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial Effect of a Relatively Low Dose of Clozapine in a Bipolar Depression Patient With Comorbid Obsessive-Compulsive Disorder and Severe Suicidality.
    Poyurovsky M; Papach P; Weizman A
    Clin Neuropharmacol; 2020; 43(5):169-170. PubMed ID: 32947431
    [No Abstract]   [Full Text] [Related]  

  • 29. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
    Kawahara T; Ueda Y; Mitsuyama Y
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical management of comorbid bipolar disorder and obsessive-compulsive disorder: A case series.
    Amerio A; Tonna M; Odone A
    Acta Biomed; 2018 Nov; 89(4):581-584. PubMed ID: 30657129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obsessive-compulsive disorder presenting with gender incongruence obsessions.
    Uvais NA; Sreeraj VS
    Asian J Psychiatr; 2017 Dec; 30():77-78. PubMed ID: 28837942
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients With Comorbid Bipolar Depression.
    Poyurovsky M; Weizman A
    Clin Neuropharmacol; 2021 Sep-Oct 01; 44(5):196-197. PubMed ID: 34456228
    [No Abstract]   [Full Text] [Related]  

  • 33. Treat the disease not the symptoms: Successful management of obsessive compulsive disorder in bipolar disorder with aripiprazole augmentation.
    Patra S
    Aust N Z J Psychiatry; 2016 Aug; 50(8):809-10. PubMed ID: 27357710
    [No Abstract]   [Full Text] [Related]  

  • 34. [The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
    Okada T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):992-8. PubMed ID: 22292193
    [No Abstract]   [Full Text] [Related]  

  • 35. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit.
    Fontenelle LF; Mendlowicz MV; Versiani M
    Psychol Med; 2004 Jan; 34(1):181; author reply 181-3. PubMed ID: 14971639
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of second-generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder.
    Monti JM
    Sleep Med; 2016 Jul; 23():89-96. PubMed ID: 27692282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: a case report.
    Chiou YJ; Lin PY; Lee Y
    Clin Neuropharmacol; 2015; 38(3):114-6. PubMed ID: 25970281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression].
    Kuroki T; Kaminiwa S; Haeno M; Kohara K; Ninomiya H
    Seishin Shinkeigaku Zasshi; 2004; 106(8):1025-9. PubMed ID: 15655899
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics.
    Spina E; de Leon J
    Expert Opin Drug Metab Toxicol; 2014 May; 10(5):721-46. PubMed ID: 24494611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aripiprazole as monotherapy at bedtime was effective for treatment of two cases of obsessive-compulsive disorder and insomnia.
    Takaki M
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E64. PubMed ID: 25093799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.